Your liver may not get as much of the spotlight as your pancreas when it comes to diabetes, but it still plays a major role in blood sugar management. Over time, insulin resistance can lead to fat buildup on the liver, inflammation, and liver scarring, often without any symptoms. Learn why liver disease is so common in people with diabetes, and what you can do now to stop it in its tracks.

Trying to determine how much insulin to dose for a meal often ends up being a wild-ass guess. After using Afrezza for over ten years, Dr. E has a few tricks up his sleeve. Discover how Afrezza's ultra-fast action can give you (or your kids) more flexibility with fewer mealtime dosing dilemmas.

After 55 years of living with type 1 diabetes, I thought I was managing my complications just fine, until I was diagnosed with ANOTHER ONE! In this article, I’ll explain why thyroid disease is so common in T1D, how it can affect your blood sugars, and the symptoms you don’t want to miss.

Game night is on! Join us Wednesday, July 8, 2026 for a free, live round of Diabetes Jeopardy, co-presented with diaTribe. Dr. Steve Edelman and Dr. Jeremy Pettus host the fun, with categories ranging from TECH TALK to PET US OR NOT PET US, with plenty to learn along the way. Open to everyone touched by diabetes, playing along from the comfort of home.

ONE 2026 is back for three unforgettable days of education, community, and just the right amount of retreat for adults living with type 1 diabetes (T1D). Join us August 14-16 at Paradise Point Resort in beautiful San Diego as we celebrate our 10th anniversary with founders Dr. Steve Edelman and Dr. Jeremy Pettus, plus an incredible lineup of speakers who mostly live with T1D too.

Starting July 1, eligible Medicare Part D patients have a much easier path to accessing FDA-approved weight management medications, including Wegovy, Zepbound, and Foundayo. This new Medicare GLP-1 Bridge Program is designed to help simplify the prescription process and improve access for patients who qualify. If you're interested in treatment for obesity or overweight, ask your healthcare provider if you're eligible.

The FDA recently approved Tzield (teplizumab) as the first treatment ever to help preserve insulin production in kids and teens ages 8-17 who’ve been recently diagnosed with type 1 diabetes. Tzield works by slowing the immune system's attack on the insulin-producing beta cells in the pancreas, helping people hold on to some of their own insulin production for a longer period of time. Until now, Tzield was only approved to delay the onset of T1D in people with stage 2 of the condition. Preserving even a small amount of insulin production can give families more time to adjust, learn, and build confidence in managing life with type 1 diabetes.

Keeping tabs on blood sugar just got a whole lot easier for families. The FDA recently approved the first over-the-counter CGM for kids. Dexcom's Stelo can now be used by children two and older who are not on insulin. Stelo uses a small wearable sensor that sends glucose readings to a smartphone app every 15 minutes, giving kids and caregivers a clearer picture of blood sugar trends without fingersticks. Stelo is not meant for people on insulin because it doesn’t have real-time alerts for high and low blood sugar. For more information, visit stelo.com.